Journey Medical (DERM) Non Operating Income (2020 - 2026)
Journey Medical's (DERM) quarterly Non Operating Income came in at -$738000.0 in Q1 2026, up 1.47% YoY from -$727318.4 in Q1 2025, and up 8.21% on a QoQ basis from -$804000.0 in Q4 2025.
Journey Medical (DERM) Non Operating Income (2020 - 2026) Analysis & Trends
Journey Medical (DERM) has 7 years of Non Operating Income data on file, last reported at -$738000.0 in Q1 2026.
- Quarterly Non Operating Income rose 1.47% year-over-year to -$738000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.2 million (down 139.52% YoY) and the FY2025 annual result came in at -$3.2 million, down 242.51% from the prior year.
- Non Operating Income climbed to -$738000.0 in Q1 2026, from -$804000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $504000.0 in Q3 2024 to a low of -$860000.0 in Q2 2025.
- A 5-year average of -$498705.9 and a median of -$578000.0 in 2022 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 239.61% in 2024, down 849.43% in 2024.
- Tracing DERM's Non Operating Income over 5 years: stood at -$634000.0 in 2022, then jumped by 113.72% to $87000.0 in 2023, then slumped by 849.43% to -$652000.0 in 2024, then retreated by 23.31% to -$804000.0 in 2025, then advanced by 8.21% to -$738000.0 in 2026.
- The last three Non Operating Income figures came in at -$738000.0 (Q1 2026), -$804000.0 (Q4 2025), and -$786000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Journey Medical | 202.90 Mn | 177.26 Mn | 12.37 Mn | -753,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -753,000.00 |
| Mar 31, 2026 | -738,000.00 |
| Dec 31, 2025 | -804,000.00 |
| Sep 30, 2025 | -786,000.00 |
| Jun 30, 2025 | -860,000.00 |
| Mar 31, 2025 | -749,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | 504,000.00 |
| Jun 30, 2024 | -434,000.00 |
| Mar 31, 2024 | -352,000.00 |
| Dec 31, 2023 | 87,000.00 |
| Sep 30, 2023 | -361,000.00 |
| Jun 30, 2023 | -710,000.00 |
| Mar 31, 2023 | -575,000.00 |
| Dec 31, 2022 | -634,000.00 |
| Sep 30, 2022 | -578,000.00 |
| Jun 30, 2022 | -450,000.00 |
| Mar 31, 2022 | -386,000.00 |
| Dec 31, 2021 | -4.36 Mn |
| Sep 30, 2021 | -1.38 Mn |